Johnson & Johnson may have to pay Indian patients for faulty implants
Govt panel likely to suggest compensation for those affected by Johnson & Johnson’s recalled hip implants
Of 1,080 patients who have registered with Johnson & Johnson’s helpline, 275 have undergone revision surgery.
Nearly seven years after US pharma giant Johnson & Johnson’s (J&J’s) hip replacement device was recalled in India in the wake of global reports of metal poisoning and high failure rate, many of those who underwent corrective surgery in the country due to the faulty device could soon be entitled to compensation.
The ministry of health and family welfare set up an expert committee two months ago, asking for a thorough investigation into the ordeal of those fitted with the defective hip implant. The committee is now on the verge of coming out with its report which is likely to seek compensation from J&J for the aggrieved patients, according to two government officials aware of the development.
The committee, headed by former dean of Maulana Azad Medical College (MAMC) Dr Arun K. Agarwal, has top orthopaedic surgeons and legal experts in it. According to the people cited above, who spoke on condition of anonymity, the committee was mandated to suggest a relief mechanism for those who suffered due to the implant.